Jackson Square Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,024
| Closed | -$4.33M | – | 12 |
|
|
2025
Q3 | $4.33M | Sell |
16,024
-4,954
| -24% | -$1.35M | 1.75% | 19 |
|
|
2025
Q2 | $5.78M | Sell |
20,978
-11,409
| -35% | -$3.1M | 2.14% | 11 |
|
|
2025
Q1 | $8.59M | Sell |
32,387
-3,040
| -9% | -$750K | 1.16% | 36 |
|
|
2024
Q4 | $8.23M | Sell |
35,427
-2,969
| -8% | -$683K | 0.86% | 37 |
|
|
2024
Q3 | $8.47M | Sell |
38,396
-14,199
| -27% | -$2.94M | 0.73% | 38 |
|
|
2024
Q2 | $10.3M | Sell |
52,595
-5,909
| -10% | -$1.22M | 0.63% | 39 |
|
|
2024
Q1 | $12.6M | Sell |
58,504
-4,798
| -8% | -$1.01M | 0.52% | 41 |
|
|
2023
Q4 | $13.3M | Sell |
63,302
-6,789
| -10% | -$1.45M | 0.43% | 38 |
|
|
2023
Q3 | $14M | Sell |
70,091
-2,054
| -3% | -$408K | 0.47% | 34 |
|
|
2023
Q2 | $13.4M | Sell |
72,145
-23,562
| -25% | -$4.35M | 0.39% | 38 |
|
|
2023
Q1 | $18.3M | Sell |
95,707
-13,432
| -12% | -$2.43M | 0.5% | 31 |
|
|
2022
Q4 | $18.4M | Buy |
+109,139
| New | +$19M | 0.49% | 37 |
|
|
2020
Q3 | – | Sell |
-1,150,360
| Closed | -$187M | – | 89 |
|
|
2020
Q2 | $187M | Sell |
1,150,360
-1,920,568
| -63% | -$344M | 0.94% | 37 |
|
|
2020
Q1 | $531M | Buy |
3,070,928
+854,012
| +39% | +$170M | 3.35% | 5 |
|
|
2019
Q4 | $445M | Buy |
2,216,916
+196,982
| +10% | +$40.4M | 2.33% | 17 |
|
|
2019
Q3 | $427M | Sell |
2,019,934
-121,640
| -6% | -$25.4M | 2.35% | 15 |
|
|
2019
Q2 | $416M | Sell |
2,141,574
-124,459
| -5% | -$22.9M | 2.15% | 19 |
|
|
2019
Q1 | $373M | Sell |
2,266,033
-9,840
| -0.4% | -$1.74M | 2.04% | 21 |
|
|
2018
Q4 | $428M | Sell |
2,275,873
-138,656
| -6% | -$25.6M | 2.63% | 14 |
|
|
2018
Q3 | $411M | Sell |
2,414,529
-166,369
| -6% | -$28M | 2.08% | 20 |
|
|
2018
Q2 | $423M | Sell |
2,580,898
-107,174
| -4% | -$17.5M | 2.16% | 18 |
|
|
2018
Q1 | $435M | Sell |
2,688,072
-85,633
| -3% | -$13.6M | 2.17% | 18 |
|
|
2017
Q4 | $405M | Buy |
2,773,705
+2,414,593
| +672% | +$344M | 2.06% | 21 |
|
|
2017
Q3 | $48.7M | Buy |
+359,112
| New | +$45.4M | 0.24% | 75 |
|
|
2016
Q1 | – | Sell |
-39,269
| Closed | -$3.56M | – | 64 |
|
|
2015
Q4 | $3.56M | Sell |
39,269
-2,977
| -7% | -$280K | 0.01% | 62 |
|
|
2015
Q3 | $3.92M | Sell |
42,246
-7,400
| -15% | -$703K | 0.02% | 60 |
|
|
2015
Q2 | $4.62M | Sell |
49,646
-7,050
| -12% | -$658K | 0.02% | 65 |
|
|
2015
Q1 | $5.37M | Sell |
56,696
-16,095
| -22% | -$1.49M | 0.02% | 64 |
|
|
2014
Q4 | $6.45M | Sell |
72,791
-43,125
| -37% | -$3.65M | 0.03% | 56 |
|
|
2014
Q3 | $9.27M | Sell |
115,916
-4,895,672
| -98% | -$369M | 0.04% | 56 |
|
|
2014
Q2 | $356M | Buy |
+5,011,588
| New | +$353M | 1.39% | 25 |
|
Other funds holding CME
Jackson Square Partners's CME Position: Q4 2025 in Review
Jackson Square Partners sold out of CME Group (CME) in Q4 2025, closing a stake of 16,024 shares — an estimated $4.33M sold.
Jackson Square Partners first reported a position in CME in Q2 2014 and held it in 31 quarters. The position peaked at $531M in Q1 2020. 1,731 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Jackson Square Partners reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
- Jackson Square Partners sold 16,024 CME Group shares in Q4 2025, an estimated $4.33M.
- Jackson Square Partners first reported a position in CME Group in Q2 2014 and held it in 31 quarters.
- Jackson Square Partners's CME Group position peaked at $531M in Q1 2020.
- 1,731 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Jackson Square Partners's 13F filing for Q4 2025.